Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...

GSK’s 3 billion pounds sterling peak sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks ...

GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects a multi-blockbuster ...

(Alliance News) - GSK PLC on Thursday said its Blenrep drug has shown overall survival benefits in patients with relapsed or refractory multiple myeloma, the third most common type of blood cancer.

GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

In September last year, the US Food and Drug Administration approved Ojjaara for the same indication. Initially developed by ...

Dr Bell reported receiving grants from the Dementia Australia Research Foundation during the conduct of the study; grants from the GlaxoSmithKline Supported Studies Programme, Amgen, Dementia Centre ...